Oxyntomodulin peptide analogs (Imperial College London)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOxyntomodulin peptide analogs (Imperial College London)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImperial College London
China Registration ClassN/A

Develop Information

Active CompaniesImperial College London
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A